Singapore-headquartered genomic medicine startup Lucence announced it has raised $20 million in Series A funding. The round was led by IHH Healthcare, one of the world’s largest integrated private healthcare groups, with 80 hospitals in 10 countries worldwide. Other participants include SGInnovate, existing investors Heliconia Capital, a subsidiary of Temasek Holdings, Lim Kaling and Koh Boon...
